Literature DB >> 8872676

Telemetry monitoring of pulmonary arterial pressure in freely moving rats.

P Hess1, M Clozel, J P Clozel.   

Abstract

Several rat models of pulmonary hypertension have been developed. However, up until now it has been difficult to monitor pulmonary arterial pressure for long periods of time. The goal of the present study was to develop a telemetry system allowing chronic monitoring of pulmonary arterial pressure in freely moving rats. For this purpose, while animals were under anesthesia, a sensing catheter was implanted into the pulmonary arterial trunk through the right ventricle. This catheter was connected to an emitter implanted in the abdomen. Validation of the system was performed in three steps. First, acutely, we controlled that the pressure signal transmitted by the telemetry system was accurate and corresponded to a signal obtained with a high-fidelity Millar catheter. Second, we evaluated the chronic consequences of implantation of the system. Third, we used the system to monitor pulmonary arterial pressure in a model of monocrotaline-induced hypertension in which the effects of bosentan, an endothelin-receptor antagonist, were evaluated. The telemetry system was reliable and did not lead to damage of the right ventricle and/or to chronic pulmonary embolism. After a recovery period of 8-10 days, mean pulmonary arterial pressure was stable. With the use of this telemetry system, it was possible to follow the increase of pulmonary arterial pressure induced by monocrotaline. In this model, bosentan decreased mean pulmonary arterial pressure by 13% (P = 0.07), suggesting a role of endothelin in this model of pulmonary hypertension. We conclude that it is possible to use this telemetry system to monitor pulmonary arterial pressure in freely moving conscious rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872676     DOI: 10.1152/jappl.1996.81.2.1027

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  13 in total

1.  Simultaneous pulmonary and systemic blood pressure and ECG Interval measurement in conscious, freely moving rats.

Authors:  Markus Rey; Edgar W Weber; Patrick D Hess
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

2.  Comparing thoracic and intra-nasal pressure transients to monitor active odor sampling during odor-guided decision making in the mouse.

Authors:  Johannes Reisert; Glen J Golden; Koichi Matsumura; Matt Smear; Dmitry Rinberg; Alan Gelperin
Journal:  J Neurosci Methods       Date:  2013-09-19       Impact factor: 2.390

3.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

Authors:  M Sean McMurtry; Stephen L Archer; Dario C Altieri; Sebastien Bonnet; Alois Haromy; Gwyneth Harry; Sandra Bonnet; Lakshmi Puttagunta; Evangelos D Michelakis
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  Contribution of oxidative stress to pulmonary arterial hypertension.

Authors:  Vincent G Demarco; Adam T Whaley-Connell; James R Sowers; Javad Habibi; Kevin C Dellsperger
Journal:  World J Cardiol       Date:  2010-10-26

5.  Novel peptide for attenuation of hypoxia-induced pulmonary hypertension via modulation of nitric oxide release and phosphodiesterase -5 activity.

Authors:  Hanbo Hu; Sergey Zharikov; Jawaharlal M Patel
Journal:  Peptides       Date:  2012-03-20       Impact factor: 3.750

6.  Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension.

Authors:  Beata Wojciak-Stothard; Vahitha B Abdul-Salam; Ka Hou Lao; Hilda Tsang; David C Irwin; Christina Lisk; Zoe Loomis; Kurt R Stenmark; John C Edwards; Stuart H Yuspa; Luke S Howard; Robert J Edwards; Christopher J Rhodes; J Simon R Gibbs; John Wharton; Lan Zhao; Martin R Wilkins
Journal:  Circulation       Date:  2014-02-06       Impact factor: 29.690

7.  Ultrasound-guided photoacoustic imaging-directed re-endothelialization of acellular vasculature leads to improved vascular performance.

Authors:  Ryan J Nagao; Yafei Ouyang; Renee Keller; Seung Yun Nam; George R Malik; Stanislav Y Emelianov; Laura J Suggs; Christine E Schmidt
Journal:  Acta Biomater       Date:  2015-12-18       Impact factor: 8.947

8.  Transforming growth factor-β inhibition and endothelin receptor blockade in rats with monocrotaline-induced pulmonary hypertension.

Authors:  Aikaterini J Megalou; Chryssoula Glava; Agapi D Vilaeti; Dimitrios L Oikonomidis; Giannis G Baltogiannis; Apostolos Papalois; Antonios P Vlahos; Theofilos M Kolettis
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

9.  A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research.

Authors:  M L Handoko; I Schalij; K Kramer; A Sebkhi; P E Postmus; W J van der Laarse; W J Paulus; A Vonk-Noordegraaf
Journal:  Pflugers Arch       Date:  2007-10-02       Impact factor: 3.657

10.  Macitentan treatment retards the progression of established pulmonary arterial hypertension in an animal model.

Authors:  I P Temple; O Monfredi; G Quigley; H Schneider; M Zi; E J Cartwright; M R Boyett; V S Mahadevan; G Hart
Journal:  Int J Cardiol       Date:  2014-10-11       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.